Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Delta Sleep-Inducing Peptide
DSIP is a neuropeptide that was originally isolated from the blood of rabbits during induced sleep. It has been studied for its effects on sleep regulation, stress reduction, and hormonal balance.
DSIP appears to modulate sleep architecture by influencing delta wave activity. It may also interact with the HPA axis, potentially reducing cortisol levels and improving stress resilience.
Early clinical studies showed improved sleep quality in patients with insomnia and normalized sleep patterns in shift workers. It has also been studied for chronic pain, withdrawal syndromes, and stress-related disorders. Research remains primarily in European and Russian literature.
Typical Dose
100mcg
Range
100-300mcg
Frequency
1x/day before bed (subcutaneous)
Route
SubQ, IM, or IV
Duration
2-4 weeks
Reconstitution
5mg vial + 2mL bacteriostatic water = 2,500mcg/mL
Notes
Administered 30–60 minutes before sleep. Cycles of 10–14 days are typical. May be combined with other sleep-support compounds. Effects are modulatory rather than sedative.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with DSIP, schedule blood work for key biomarkers, and track your results.
Build Protocol with DSIPThis platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs